O	0	1	A	A	DT	B-NP
O	2	7	novel	novel	JJ	I-NP
O	8	17	conotoxin	conotoxin	NN	I-NP
O	18	22	from	from	IN	B-PP
O	23	28	Conus	Conus	NNP	B-NP
O	29	40	delessertii	delessertii	NN	I-NP
O	41	45	with	with	IN	B-PP
O	46	65	posttranslationally	posttranslationally	RB	B-NP
O	66	74	modified	modify	VBN	I-NP
O	75	81	lysine	lysine	NN	I-NP
O	82	90	residues	residue	NNS	I-NP
O	90	91	.	.	.	O

O	92	93	A	A	DT	B-NP
O	94	99	major	major	JJ	I-NP
O	100	107	peptide	peptide	NN	I-NP
O	107	108	,	,	,	O
O	109	114	de13a	de13a	NN	B-NP
O	115	119	from	from	IN	B-PP
O	120	123	the	the	DT	B-NP
O	124	129	crude	crude	JJ	I-NP
B-Organism_substance	130	135	venom	venom	NN	I-NP
O	136	138	of	of	IN	B-PP
O	139	144	Conus	Conus	NNP	B-NP
O	145	156	delessertii	delessertii	NN	I-NP
O	157	166	collected	collect	VBN	B-VP
O	167	169	in	in	IN	B-PP
O	170	173	the	the	DT	B-NP
O	174	181	Yucatan	Yucatan	NNP	I-NP
O	182	189	Channel	Channel	NNP	I-NP
O	189	190	,	,	,	O
O	191	197	Mexico	Mexico	NNP	B-NP
O	197	198	,	,	,	O
O	199	202	was	be	VBD	B-VP
O	203	211	purified	purify	VBN	I-VP
O	211	212	.	.	.	O

O	213	216	The	The	DT	B-NP
O	217	224	peptide	peptide	NN	I-NP
O	225	228	had	have	VBD	B-VP
O	229	230	a	a	DT	B-NP
O	231	235	high	high	JJ	I-NP
O	236	243	content	content	NN	I-NP
O	244	246	of	of	IN	B-PP
O	247	266	posttranslationally	posttranslationally	RB	B-NP
O	267	275	modified	modify	VBN	I-NP
O	276	281	amino	amino	NN	I-NP
O	282	287	acids	acid	NNS	I-NP
O	287	288	,	,	,	O
O	289	298	including	include	VBG	B-PP
O	299	300	6	6	CD	B-NP
O	300	301	-	-	HYPH	I-NP
O	301	316	bromotryptophan	bromotryptophan	NN	I-NP
O	317	320	and	and	CC	O
O	321	322	a	a	DT	B-NP
O	323	334	nonstandard	nonstandard	JJ	I-NP
O	335	340	amino	amino	JJ	I-NP
O	341	345	acid	acid	NN	I-NP
O	346	350	that	that	WDT	B-NP
O	351	357	proved	prove	VBD	B-VP
O	358	360	to	to	TO	I-VP
O	361	363	be	be	VB	I-VP
O	364	365	5	5	CD	B-NP
O	365	366	-	-	HYPH	I-NP
O	366	379	hydroxylysine	hydroxylysine	NN	I-NP
O	379	380	.	.	.	O

O	381	385	This	This	DT	B-NP
O	386	388	is	be	VBZ	B-VP
O	389	392	the	the	DT	B-NP
O	393	398	first	first	JJ	I-NP
O	399	405	report	report	NN	I-NP
O	406	408	of	of	IN	B-PP
O	409	410	5	5	CD	B-NP
O	410	411	-	-	HYPH	I-NP
O	411	424	hydroxylysine	hydroxylysine	NN	I-NP
O	425	433	residues	residue	NNS	I-NP
O	434	436	in	in	IN	B-PP
O	437	447	conotoxins	conotoxin	NNS	B-NP
O	447	448	.	.	.	O

O	449	452	The	The	DT	B-NP
O	453	461	sequence	sequence	NN	I-NP
O	462	470	analysis	analysis	NN	I-NP
O	470	471	,	,	,	O
O	472	480	together	together	RB	B-ADVP
O	481	485	with	with	IN	B-PP
O	486	490	cDNA	cDNA	NN	B-NP
O	491	498	cloning	cloning	NN	I-NP
O	499	502	and	and	CC	O
O	503	504	a	a	DT	B-NP
O	505	509	mass	mass	NN	I-NP
O	510	523	determination	determination	NN	I-NP
O	524	525	(	(	(	O
O	525	537	monoisotopic	monoisotopic	JJ	B-NP
O	538	542	mass	mass	NN	I-NP
O	543	545	of	of	IN	B-PP
O	546	550	3486	3486	CD	B-NP
O	550	551	.	.	.	O
O	551	553	76	76	CD	B-NP
O	554	556	Da	Da	NN	I-NP
O	556	557	)	)	)	O
O	557	558	,	,	,	O
O	559	570	established	establish	VBD	B-VP
O	571	575	that	that	IN	B-SBAR
O	576	579	the	the	DT	B-NP
O	580	586	mature	mature	JJ	I-NP
O	587	592	toxin	toxin	NN	I-NP
O	593	596	has	have	VBZ	B-VP
O	597	600	the	the	DT	B-NP
O	601	609	sequence	sequence	NN	I-NP
O	610	642	DCOTSCOTTCANGWECCKGYOCVNKACSGCTH	DCOTSCOTTCANGWECCKGYOCVNKACSGCTH	NN	I-NP
O	642	643	,	,	,	O
O	644	649	where	where	WRB	B-ADVP
O	650	651	O	O	NN	B-NP
O	652	654	is	be	VBZ	B-VP
O	655	656	4	4	CD	B-NP
O	656	657	-	-	HYPH	I-NP
O	657	671	hydroxyproline	hydroxyproline	NN	I-NP
O	671	672	,	,	,	O
O	673	674	W	W	NN	B-NP
O	675	676	6	6	CD	I-NP
O	676	677	-	-	HYPH	I-NP
O	677	692	bromotryptophan	bromotryptophan	NN	I-NP
O	692	693	,	,	,	O
O	694	697	and	and	CC	O
O	698	699	K	K	NN	B-NP
O	700	701	5	5	CD	I-NP
O	701	702	-	-	HYPH	I-NP
O	702	715	hydroxylysine	hydroxylysine	NN	I-NP
O	715	716	,	,	,	O
O	717	720	the	the	DT	B-NP
O	721	729	asterisk	asterisk	NN	I-NP
O	730	740	represents	represent	VBZ	B-VP
O	741	744	the	the	DT	B-NP
O	745	753	amidated	amidate	VBN	I-NP
O	754	755	C	C	NN	I-NP
O	755	756	-	-	HYPH	I-NP
O	756	764	terminus	terminus	NN	I-NP
O	764	765	,	,	,	O
O	766	769	and	and	CC	O
O	770	773	the	the	DT	B-NP
O	774	784	calculated	calculate	VBN	I-NP
O	785	797	monoisotopic	monoisotopic	JJ	I-NP
O	798	802	mass	mass	NN	I-NP
O	803	805	is	be	VBZ	B-VP
O	806	810	3487	3487	CD	B-NP
O	810	811	.	.	.	O
O	811	813	09	09	CD	B-NP
O	814	816	Da	Da	NNP	I-NP
O	816	817	.	.	.	O

O	818	821	The	The	DT	B-NP
O	822	827	eight	eight	CD	I-NP
O	828	831	Cys	Cys	NN	I-NP
O	832	840	residues	residue	NNS	I-NP
O	841	844	are	be	VBP	B-VP
O	845	853	arranged	arrange	VBN	I-VP
O	854	856	in	in	IN	B-PP
O	857	858	a	a	DT	B-NP
O	859	866	pattern	pattern	NN	I-NP
O	867	868	(	(	(	O
O	868	869	C	C	NN	B-NP
O	869	870	-	-	HYPH	B-NP
O	870	871	C	C	NN	I-NP
O	871	872	-	-	HYPH	B-NP
O	872	873	C	C	NN	I-NP
O	873	874	-	-	HYPH	B-NP
O	874	876	CC	CC	NN	I-NP
O	876	877	-	-	HYPH	B-NP
O	877	878	C	C	NN	I-NP
O	878	879	-	-	HYPH	B-NP
O	879	880	C	C	NN	I-NP
O	880	881	-	-	HYPH	I-NP
O	881	882	C	C	NN	I-NP
O	882	883	)	)	)	O
O	884	887	not	not	RB	B-VP
O	888	897	described	describe	VBN	I-VP
O	898	908	previously	previously	RB	B-ADVP
O	909	911	in	in	IN	B-PP
O	912	922	conotoxins	conotoxin	NNS	B-NP
O	922	923	.	.	.	O

O	924	928	This	This	DT	B-NP
O	929	940	arrangement	arrangement	NN	I-NP
O	940	941	,	,	,	O
O	942	945	for	for	IN	B-PP
O	946	951	which	which	WDT	B-NP
O	952	954	we	we	PRP	B-NP
O	955	962	propose	propose	VBP	B-VP
O	963	966	the	the	DT	B-NP
O	967	978	designation	designation	NN	I-NP
O	979	981	of	of	IN	B-PP
O	982	991	framework	framework	NN	B-NP
O	992	993	#	#	#	B-NP
O	993	995	13	13	CD	I-NP
O	996	998	or	or	CC	I-NP
O	999	1003	XIII	XIII	CD	I-NP
O	1003	1004	,	,	,	O
O	1005	1012	differs	differ	VBZ	B-VP
O	1013	1017	from	from	IN	B-PP
O	1018	1021	the	the	DT	B-NP
O	1022	1026	ones	one	NNS	I-NP
O	1027	1028	(	(	(	O
O	1028	1029	C	C	NN	B-NP
O	1029	1030	-	-	HYPH	B-NP
O	1030	1031	C	C	NN	I-NP
O	1031	1032	-	-	HYPH	B-NP
O	1032	1034	CC	CC	NN	I-NP
O	1034	1035	-	-	HYPH	B-NP
O	1035	1037	CC	CC	NN	I-NP
O	1037	1038	-	-	HYPH	I-NP
O	1038	1039	C	C	NN	I-NP
O	1039	1040	-	-	HYPH	I-NP
O	1040	1041	C	C	NN	I-NP
O	1042	1045	and	and	CC	I-NP
O	1046	1047	C	C	NN	I-NP
O	1047	1048	-	-	HYPH	B-NP
O	1048	1049	C	C	NN	I-NP
O	1049	1050	-	-	HYPH	B-NP
O	1050	1051	C	C	NN	I-NP
O	1051	1052	-	-	HYPH	B-NP
O	1052	1053	C	C	NN	I-NP
O	1053	1054	-	-	HYPH	B-NP
O	1054	1056	CC	CC	NN	I-NP
O	1056	1057	-	-	HYPH	B-NP
O	1057	1058	C	C	NN	I-NP
O	1058	1059	-	-	HYPH	I-NP
O	1059	1060	C	C	NN	I-NP
O	1060	1061	)	)	)	O
O	1062	1069	present	present	JJ	B-ADJP
O	1070	1072	in	in	IN	B-PP
O	1073	1078	other	other	JJ	B-NP
O	1079	1089	conotoxins	conotoxin	NNS	I-NP
O	1090	1095	which	which	WDT	B-NP
O	1096	1100	also	also	RB	B-ADVP
O	1101	1108	contain	contain	VBP	B-VP
O	1109	1114	eight	eight	CD	B-NP
O	1115	1118	Cys	Cys	NN	I-NP
O	1119	1127	residues	residue	NNS	I-NP
O	1127	1128	.	.	.	O

O	1129	1133	This	This	DT	B-NP
O	1134	1141	peptide	peptide	NN	I-NP
O	1142	1146	thus	thus	RB	B-ADVP
O	1147	1154	defines	define	VBZ	B-VP
O	1155	1156	a	a	DT	B-NP
O	1157	1162	novel	novel	JJ	I-NP
O	1163	1168	class	class	NN	I-NP
O	1169	1171	of	of	IN	B-PP
O	1172	1182	conotoxins	conotoxin	NNS	B-NP
O	1182	1183	,	,	,	O
O	1184	1188	with	with	IN	B-PP
O	1189	1190	a	a	DT	B-NP
O	1191	1194	new	new	JJ	I-NP
O	1195	1212	posttranslational	posttranslational	JJ	I-NP
O	1213	1225	modification	modification	NN	I-NP
O	1226	1229	not	not	RB	O
O	1230	1240	previously	previously	RB	B-VP
O	1241	1246	found	find	VBN	I-VP
O	1247	1249	in	in	IN	B-PP
O	1250	1255	other	other	JJ	B-NP
O	1256	1261	Conus	Conus	NNP	I-NP
O	1262	1269	peptide	peptide	NN	I-NP
O	1270	1278	families	family	NNS	I-NP
O	1278	1279	.	.	.	O

